Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Radiolabeled somatostatin analogue with potential for PET imaging and targeted radiotherapy

June 1, 1999

Novel matrix metalloproteinase inhibitor selectively inhibits rat osteosarcoma lung metastasis

June 1, 1999

Imidazole-based protein farnesyltransferase inhibitors for cancer

June 1, 1999

More on protein farnesyltransferase inhibitors in development at Merck

June 1, 1999

Chinese scientists discover new MDR reversal agents during search for cardiovascular agents

June 1, 1999

Recombinant enzyme plus gene therapy: a unique combination therapy for cancer

May 31, 1999

CPMP recommends expanded approval of Temodal for brain tumor therapy

May 31, 1999

Ilex initiates clinical testing of vitamin D3 analogue

May 31, 1999

EntreMed announces sites for Endostatin phase I clinical trials

May 31, 1999

More news from ASCO: safety and pharmacokinetics of squalamine examined in phase I trials

May 28, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...